low histamine diet

The Low Histamine Diet and Low Histamine Probiotics: A Practical Clinical Guide

www.directintegrativecare.com

Yoon Hang Kim, MD, MPH | www.directintegrativecare.com

MEDICAL DISCLAIMER: This article is intended for educational purposes only and does not constitute medical advice. The information provided should not be used to diagnose, treat, or manage any medical condition. Individual responses to dietary interventions and probiotics vary widely. Always consult with a qualified healthcare provider before making significant dietary changes or starting any supplement regimen, particularly if you have a chronic health condition, are pregnant, or are taking medications.

Introduction: When Histamine Becomes a Problem

Histamine is a biogenic amine with essential physiological roles — it mediates immune responses, modulates gastric acid secretion, functions as a neurotransmitter, and participates in the regulation of circadian rhythms. Under normal conditions, the enzyme diamine oxidase (DAO) — produced primarily in the intestinal mucosa — efficiently catabolizes dietary histamine before it can accumulate to symptomatic levels. A second enzyme, histamine N-methyltransferase (HNMT), handles intracellular histamine degradation.

Histamine intolerance (HIT) occurs when this enzymatic capacity is overwhelmed, most commonly due to impaired DAO activity, excessive dietary histamine load, or gut dysbiosis that tips the balance toward histamine-producing bacteria. The result is a broad and frustrating symptom constellation that can mimic allergic disease, irritable bowel syndrome, migraine, and autonomic dysfunction — while standard allergy testing returns negative.

Mast cell activation syndrome (MCAS) represents an overlapping but distinct condition in which mast cells pathologically release histamine and other mediators in excess. Though the mechanisms differ from classic HIT, the dietary and probiotic strategies are largely parallel, and clinically the two conditions frequently coexist.

This article summarizes the evidence-based framework for a low histamine diet and explores strain-specific probiotic considerations — an area of growing importance in integrative gastroenterology, integrative oncology, and functional immune care.

Understanding the Histamine Load: Why Diet Matters

Histamine accumulates in foods through two primary pathways: bacterial decarboxylation of the amino acid histidine during fermentation, aging, or prolonged storage; and enzymatic activity within the food itself. This means that freshness is the single most important variable in a low histamine diet — the same piece of fish that is safe when consumed immediately after cooking may be a significant histamine load as leftovers the following day.

Several additional factors compound the dietary picture:

DAO inhibitors: Alcohol (especially wine and beer) directly suppresses DAO activity. Certain medications — including NSAIDs, ACE inhibitors, diuretics, and some antihistamines paradoxically — can also reduce DAO function.
Histamine liberators: Foods such as strawberries, citrus, tomatoes, shellfish, and certain additives (benzoates, sulfites, artificial colors) do not necessarily contain high histamine themselves but can trigger mast cell degranulation and endogenous histamine release.
Biogenic amine synergy: Other biogenic amines — putrescine, cadaverine, tyramine — compete with histamine for DAO degradation, effectively increasing the histamine burden even when histamine content per se is modest.

Clinically, this means that a strict low histamine diet must address not only histamine-rich foods but also histamine liberators and DAO-blocking substances. The practical result is a diet centered on very fresh, simply prepared, minimally processed foods.

Core Principles of the Low Histamine Diet

The Low Histamine Diet — Five Clinical Principles

Fresh is paramount. Purchase and cook on the same day whenever possible. Flash-frozen fish and meats (IQF — individually quick frozen) are acceptable alternatives.
Minimize storage time. Histamine levels rise with refrigeration time. Many protocols restrict leftovers to 24 hours or eliminate them entirely during the acute elimination phase.
Eliminate fermented and aged foods. This includes all aged cheeses, cured meats, fermented vegetables (sauerkraut, kimchi), vinegar-containing condiments, soy sauce, miso, and alcoholic beverages.
Address histamine liberators and DAO inhibitors. In symptomatic patients, citrus, strawberries, tomatoes, spinach, and alcohol warrant restriction during the elimination phase regardless of their direct histamine content.
Frame the diet as a time-limited elimination trial. Standard protocols run 2–4 weeks under clinician or registered dietitian supervision, followed by a structured reintroduction to identify individual triggers and prevent unnecessary long-term restriction.

Low Histamine Foods: A Reference Table

The following table summarizes commonly referenced low histamine and high histamine foods by category. Individual tolerance varies significantly — food and symptom journaling is strongly encouraged during both the elimination and reintroduction phases.

Food Category	Generally Well-Tolerated (Low Histamine)	Commonly Problematic (High Histamine or Triggers)
Protein	Fresh chicken, turkey, beef; eggs; fresh or IQF white fish; certain legumes (excluding chickpeas, lentils, red beans, soy)	Aged/processed meats (salami, bacon, ham); canned or smoked fish; shellfish in sensitive patients
Dairy	Fresh milk and cream; uncultured cheeses — cottage, cream cheese, ricotta, mascarpone, fresh mozzarella	Aged cheeses (cheddar, parmesan, blue); fermented dairy (yogurt, kefir); sour cream
Grains & Starches	Rice, quinoa, millet, corn, plain pasta, potatoes, sweet potatoes	Highly processed breads; some patients also restrict wheat on an experimental basis
Fruits	Apples, pears, melon, select berries — based on individual tolerance	Citrus fruits, strawberries, overripe bananas, many dried fruits
Vegetables	Most fresh vegetables: zucchini, carrots, green beans, lettuces, cucumber, broccoli	Spinach, tomatoes, eggplant, avocado — often restricted during strict elimination
Fats & Seasonings	Olive oil, fresh oils, salt, mild herbs (parsley, thyme), garlic	Fermented soy sauce, vinegar-containing condiments (ketchup, pickles, mustard), additive-rich sauces
Beverages	Water, select herbal teas, additive-free coconut or almond milk	Alcohol (especially wine and beer), kombucha, energy drinks, cola; coffee and black tea in sensitive individuals

A practical sample day on a low histamine diet might include: oatmeal with fresh pear and coconut milk for breakfast; grilled chicken with zucchini and roasted carrots for lunch; sliced apple with sunflower seed butter as a snack; and baked white fish with sweet potato and fresh green beans for dinner.

The Role of the Gut Microbiome in Histamine Intolerance

Intestinal dysbiosis is increasingly recognized as a key driver of histamine intolerance — and a critical target for treatment beyond dietary restriction alone. Certain gut bacterial species, including strains of Lactobacillus casei, some clostridia, Morganella morganii, and Hafnia alvei, produce histidine decarboxylase, the enzyme responsible for converting histidine to histamine in the gut lumen. When these species overgrow relative to histamine-degrading commensals, the histamine burden rises independently of dietary intake.

This has important therapeutic implications. Simply avoiding dietary histamine without addressing the underlying dysbiosis is analogous to mopping the floor without turning off the faucet — symptom control may be partial and unsustained. A comprehensive approach includes dietary management alongside targeted probiotic therapy designed to restore microbial balance, reduce histamine-producing species, and — where specific strains support it — enhance luminal histamine degradation.

Additionally, intestinal hyperpermeability ('leaky gut') reduces mucosal DAO production by damaging the enterocytes responsible for its synthesis. This creates a vicious cycle: dysbiosis increases histamine, histamine contributes to barrier disruption, and barrier disruption further impairs DAO activity. Gut-healing interventions — including zinc, L-glutamine, and appropriate probiotic support — are therefore often integrated into clinical histamine intolerance management.

Low Histamine Probiotics: Strain Selection Matters

Not all probiotics are histamine-neutral. Several Lactobacillus strains — particularly some within the L. casei group (including L. casei Shirota and certain commercial kefir strains) — carry genes for histidine decarboxylase and have been shown under some conditions to produce histamine in vitro or in vivo. For histamine-sensitive patients, this distinction is clinically meaningful: the wrong probiotic formulation can worsen symptoms even while the patient adheres strictly to a low histamine diet.

The evidence base is still evolving, and histamine production is strain-specific — generalizations to the species level are imprecise. Nevertheless, the following framework reflects current consensus within integrative and functional medicine practice:

Preferred Strains: Histamine-Neutral or Degrading

Lactobacillus rhamnosus GG (LGG): The most widely studied probiotic strain globally. Consistently classified as histamine-neutral to potentially degrading. Supports intestinal barrier integrity, reduces intestinal permeability markers, and has a strong safety profile across populations.
Lactobacillus plantarum: Several strains demonstrate DAO-like activity and are histamine-neutral. Commonly included in MCAS-targeted and histamine intolerance-targeted commercial formulations.
Lactobacillus salivarius: Histamine-neutral; supports oral and gut mucosal immunity. Frequently present in HIT-friendly probiotic blends.
Bifidobacterium species (B. infantis, B. longum, B. bifidum, B. lactis, B. breve): As a group, Bifidobacteria are non-histamine producing and are broadly recommended for histamine-sensitive individuals. B. longum in particular has demonstrated anti-inflammatory and barrier-supportive properties in controlled trials.
Saccharomyces boulardii: A beneficial yeast with robust evidence for dysbiosis resolution, C. difficile prevention, and IBS symptom management. Non-histamine producing. Addresses the underlying microbial imbalance that can drive HIT.

Strains to Use with Caution

Lactobacillus casei / L. reuteri / L. bulgaricus: These strains are most commonly flagged in histamine intolerance literature as potentially histamine-producing. Evidence is strain-specific and inconsistent — not all commercial strains within these species produce histamine — but for symptomatic patients in the acute phase, caution is warranted. Individual trial with close monitoring is appropriate if clinical rationale warrants inclusion.

Probiotic Strain Reference Table

Strain	Histamine Profile	Clinical Rationale
Lactobacillus rhamnosus GG	Histamine-degrading / neutral	Supports intestinal barrier; among the most evidence-based strains for gut health; frequently referenced in histamine intolerance communities
Lactobacillus plantarum	Histamine-neutral to degrading	Produces DAO enzyme in some strains; broad gut microbiome support; commonly included in MCAS-friendly formulas
Lactobacillus salivarius	Histamine-neutral	Oral and gut mucosal support; included in targeted HIT probiotic blends
Bifidobacterium infantis	Non-histamine producing	Promotes regulatory immune responses; gut lining support; considered safe for histamine-sensitive patients
Bifidobacterium longum	Non-histamine producing	Anti-inflammatory gut effects; reduces intestinal permeability markers in research
Bifidobacterium bifidum	Non-histamine producing	Supports mucosal immunity; part of foundational gut microbiome
Bifidobacterium lactis / breve	Non-histamine producing	Broad tolerability; frequently used in pediatric and adult HIT protocols
Saccharomyces boulardii	Non-histamine producing (yeast)	Reduces intestinal dysbiosis; clinically useful for traveler's diarrhea, C. diff, IBS; resolves dysbiosis that may drive HIT
L. casei / L. reuteri / L. bulgaricus	Potentially histamine-producing (strain-specific)	Commonly flagged as higher-risk in HIT/MCAS communities; evidence is strain-level and not uniform — review product-specific data

Clinical Product Examples

The following products have been formulated with histamine sensitivity in mind. This is not an endorsement, and formulations are subject to change — clinicians and patients should always review the current strain list at the subspecies level before recommending or purchasing.

ProBiota HistaminX (Seeking Health): Contains B. infantis, B. bifidum, B. longum, B. lactis, B. breve, L. plantarum, and L. salivarius. Explicitly formulated to exclude histamine-producing strains. A widely referenced option in integrative and MCAS clinical communities.
Hista-Biotic (Fact vs Fitness): A commercially marketed low histamine probiotic blend. Review strain list with each purchase as formulations can change.
Triple probiotic therapy (clinical approach, Ruscio Institute): An evidence-informed approach combining a Lactobacillus-Bifidobacterium blend, S. boulardii, and soil-based Bacillus species as a multi-category strategy. This approach targets underlying gut dysbiosis comprehensively, with the hypothesis that resolving dysbiosis reduces the microbial histamine burden regardless of explicit low-histamine strain selection.

DAO Support and Co-Factor Considerations

For patients with confirmed or suspected DAO deficiency, dietary and probiotic interventions are often complemented by DAO enzyme supplementation (taken before meals) and nutritional co-factors that support DAO synthesis. Key co-factors include:

Vitamin B6 (P5P form): Required cofactor for DAO enzyme function. Deficiency may impair DAO activity independent of genetic factors.
Copper: Essential for DAO activity. Low copper status correlates with reduced histamine degradation capacity.
Vitamin C: Supports DAO activity and promotes histamine metabolism via a separate pathway. Also useful as a mast cell stabilizer in higher doses.
Zinc: Supports mucosal integrity and DAO production. Often depleted in the context of gut dysbiosis and intestinal hyperpermeability.

A medication review is also warranted in any patient presenting with histamine intolerance symptoms. NSAIDs, ACE inhibitors, loop diuretics, and several antidepressants have documented DAO-inhibiting properties and can unmask or worsen HIT in susceptible individuals.

Practical Protocol: From Elimination to Reintroduction

A Step-by-Step Clinical Framework

Phase 1 — Strict elimination (Weeks 1–4): Remove all high-histamine foods, histamine liberators, and DAO inhibitors. Use only fresh or IQF proteins. Restrict leftovers to 24 hours or eliminate entirely. Avoid fermented foods, vinegar-containing condiments, alcohol, and the high-risk vegetables listed above.
Probiotic introduction — start low, go slow: Introduce a single histamine-neutral or histamine-lowering strain (e.g., Bifidobacterium longum or LGG) at low dose. Monitor for symptom flare over 5–7 days before adding additional strains or increasing dose.
Symptom tracking: Use a structured food and symptom diary. Track the full symptom profile — flushing, headache, urticaria, GI upset, palpitations, nasal congestion — along with food intake, leftovers consumed, and supplement changes.
Phase 2 — Structured reintroduction (beginning Week 5): Reintroduce one food category at a time, every 3–5 days. Begin with lower-risk categories (e.g., tomatoes before aged cheese). This identifies individual thresholds and prevents unnecessary long-term restriction.
Phase 3 — Maintenance and root cause treatment: Address underlying dysbiosis, intestinal hyperpermeability, and any modifiable DAO-inhibiting medication factors. The goal is to restore enough endogenous histamine-degrading capacity that dietary restriction can be liberalized over time.

Integrative Medicine Perspective: Beyond the Elimination Diet

In integrative practice, histamine intolerance is rarely an isolated finding. It frequently coexists with MCAS, small intestinal bacterial overgrowth (SIBO), mold illness, Lyme disease, long COVID, and connective tissue disorders such as hypermobile Ehlers-Danlos syndrome (hEDS). Each of these conditions can independently drive mast cell activation and impair DAO function, creating a compound histamine burden that dietary manipulation alone cannot fully address.

A comprehensive integrative evaluation for the histamine-intolerant patient includes assessment of gut microbiome composition, intestinal permeability, MCAS criteria, SIBO testing, and, where clinically indicated, evaluation for underlying infections or connective tissue abnormalities. Low-dose naltrexone (LDN), for example, has demonstrated mast cell-stabilizing and anti-inflammatory properties that may reduce overall mast cell reactivity and indirectly lower the clinical histamine burden — a consideration particularly relevant in patients with overlapping MCAS and neuroimmune conditions.

Dietary intervention, while foundational, is most powerful when embedded within this broader systems-based approach — addressing not just what the patient eats, but why their system has become unable to tolerate normal histamine loads in the first place.

Conclusion

The low histamine diet is an effective, evidence-informed intervention for histamine intolerance and related mast cell-driven conditions. Its success depends on strict attention to food freshness, systematic elimination of high-histamine and histamine-liberating foods, and a structured approach to reintroduction that preserves nutritional adequacy. When integrated with strain-specific probiotic therapy targeting histamine-neutral or histamine-degrading organisms, dysbiosis resolution, gut barrier repair, and co-factor support, it forms the nutritional backbone of a comprehensive integrative treatment strategy.

As with all elimination approaches, the diet is most therapeutic when supervised, time-limited, and individualized — and when it serves as a diagnostic and therapeutic tool in the context of a larger clinical picture, rather than a permanent restriction imposed without a clear understanding of the root cause.

References

Key references supporting this article are listed below. PMID numbers are provided where available for PubMed access.

Schnedl WJ, Lackner S, Enko D, et al. Evaluation of symptoms and symptom combinations in histamine intolerance. Intest Res. 2019;17(3):427–433. PMID: 30836734
Maintz L, Novak N. Histamine and histamine intolerance. Am J Clin Nutr. 2007;85(5):1185–1196. PMID: 17490952
Schink M, Konturek PC, Tietz E, et al. Microbial patterns in patients with histamine intolerance. J Physiol Pharmacol. 2018;69(4). PMID: 30422835
Comas-Basté O, Sánchez-Pérez S, Veciana-Nogués MT, et al. Histamine intolerance: the current state of the art. Biomolecules. 2020;10(8):1181. PMID: 32824107
Manzotti G, Breda D, Di Gioacchino M, Burastero SE. Serum diamine oxidase activity in patients with histamine intolerance. Int J Immunopathol Pharmacol. 2016;29(1):105–111. PMID: 26574515
Hrubisko M, Danis R, Huorka M, Wawruch M. Histamine intolerance — the more we know the less we know. A review. Nutrients. 2021;13(7):2228. PMID: 34209583
Thomas CM, Hong T, van Pijkeren JP, et al. Histamine derived from probiotic Lactobacillus reuteri suppresses TNF via modulation of PKA and ERK signaling. PLoS One. 2012;7(2):e31951. PMID: 22384111
Fuentes MV, Torrescasana JM. Low histamine diet — a systematic approach. Allergol Immunopathol (Madr). 2017 (review framework from clinical practice guidelines).
Ring J, Messmer K. Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet. 1977;1(8009):466–469. PMID: 65943 [foundational histamine release mechanism reference]
Ruscio M. Does histamine intolerance require special probiotics? Ruscio Institute for Functional Medicine. Clinical review 2022. Available at: drruscio.com

—

About Dr. Kim

Dr. Yoon Hang “John” Kim is a board-certified integrative medicine physician with over 20 years of clinical experience. He completed his integrative medicine fellowship at the University of Arizona under Dr. Andrew Weil and holds certifications in preventive medicine, medical acupuncture, and integrative/holistic medicine. Through his telemedicine practice, Dr. Kim specializes in utilizing LDN or Low Dose Naltrexone for treating autoimmune conditions, chronic pain, integrative oncology, and complex conditions including fibromyalgia, chronic fatigue, MCAS, and mold toxicity. He is the author of three books and more than 20 articles, and has helped establish integrative medicine programs at institutions nationwide.

Professional: www.yoonhangkim.com | Clinical: www.directintegrativecare.com

www.directintegrativecare.com

Membership-Based Integrative Telemedicine | www.directintegrativecare.com

Serving patients in Iowa, Illinois, Missouri, Texas, Georgia, and Florida